(Total Views: 391)
Posted On: 10/01/2020 1:21:05 PM
Post# of 11802
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Saliva-based glucose device developer GBS sets terms for $20 million IPO
https://www.nasdaq.com/articles/saliva-based-...2020-10-01
https://gbs.inc/saliva-glucose/
A way for DECN too?
https://www.nasdaq.com/articles/saliva-based-...2020-10-01
https://gbs.inc/saliva-glucose/
A way for DECN too?
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)